Source: Journal of Sexual Medicine. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
CARNEIRO, Fernando Silva et al. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Journal of Sexual Medicine, v. 5, n. 12, p. 2793-2807, 2008Tradução . . Acesso em: 12 nov. 2024.APA
Carneiro, F. S., Nunes, K. P., Giachini, F. R. C., Lima, V. V., Carneiro, Z. N., Nogueira, E. F., et al. (2008). Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Journal of Sexual Medicine, 5( 12), 2793-2807.NLM
Carneiro FS, Nunes KP, Giachini FRC, Lima VV, Carneiro ZN, Nogueira EF, Leite R, Ergul A, Rainey WE, Webb RC, Passaglia R de CAT. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Journal of Sexual Medicine. 2008 ; 5( 12): 2793-2807.[citado 2024 nov. 12 ]Vancouver
Carneiro FS, Nunes KP, Giachini FRC, Lima VV, Carneiro ZN, Nogueira EF, Leite R, Ergul A, Rainey WE, Webb RC, Passaglia R de CAT. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. Journal of Sexual Medicine. 2008 ; 5( 12): 2793-2807.[citado 2024 nov. 12 ]